Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Varian Medical Q1 Profit Rises, Guides Q2 EPS Below View

RELATED NEWS
Trade VAR now with 

Varian Medical Systems Inc. (VAR: Quote) Wednesday reported higher profit for the first quarter as revenue increased 8 percent with improvements in both segments. However, earnings per share were less than what analysts had expected. The company guided second-quarter profit below Street view and raised the lower end of its full year profit outlook. The stock fell over 4 percent in after-hours trading.

Dow Wilson, CEO, said, ''The company's first quarter revenues and net earnings grew in line with our expectations for both our Oncology Systems and X-Ray Products businesses. Margins were also in line with our expectations. Excluding the restructuring charge in the quarter, our operating margin improved versus the year-ago quarter.''

Net income climbed to $95.3 million or $0.86 per share from $90.2 million or $0.79 per share in the year-ago quarter.

The latest results included a $4.1 million restructuring charge related to an enhanced retirement program.

On average, 14 analysts polled by Thomson Reuters expected the company to earn $0.87 per share for the quarter. Analysts' estimates typically exclude special items.

Gross margin dropped to 42.9 percent from 43.0 percent.

Revenues rose 8 percent to $678.4 million from $625.3 million. Analysts had a consensus revenue estimate of $676.14 million for the quarter.

Revenue from Oncology Systems increased 8 percent to $524.3 million, and X-Ray Products revenue increased 18 percent to $132.9 million. Net orders climbed to $619.2 million from $606.1 million in the prior year, as a small decline in Oncology Systems, due to weaker orders in Europe and Asia, was offset by increased orders at X-Ray Products. Looking forward to the second quarter, net earnings per share are estimated in the range of $0.98 to $1.03 with the balance of restructuring charges from the enhanced retirement program. The company expects revenues to increase 5 to 6 percent year-over-year.

Analysts currently expect the company to earn $1.04 per share on revenue of $774.26 million for the second quarter.

For fiscal year 2013, the company continues to believe that revenues could increase 8 to 9 percent. Net earnings per share for fiscal 2013 could be in the range of $4.08 to $4.16. Previously, the company expected fiscal 2013 earnings to be in the range of $4.06 to $4.16 per share.

Analysts currently expect the company to earn $4.12 per share on revenue of $3.04 billion for the fiscal year 2013.

VAR closed down 0.3 percent on Wednesday at $74.91, and fell 4.2 percent in the extended trade.

Register
To receive FREE breaking news email alerts for Varian Medical Systems and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Following the long, holiday weekend, stocks may move to the upside in early trading on Tuesday. The major index futures are currently pointing to a modestly higher open for the markets, with the Dow futures up by 15 points. The Swiss economy stalled in the second quarter as the improvement in household spending was insufficient to offset the weakness in exports and investment in construction. Gross domestic product remained flat from the first quarter, when it accelerated to 0.5 percent, the State Secretariat for Economic Affairs said Tuesday. Economists had expected GDP to rise 0.5 percent in the second quarter. Policymakers of Reserve Bank of Australia decided to maintain its record low interest rate once again as they continue to assess that the most prudent course is a period of stability in interest rates. The monetary policy board retained the cash rate at 2.50 percent. The rate has been at the current level since August 2013.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.